Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perla Matar

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|September 5, 2025
Mesenchymal stromal cells 2.0: thinking outside the boxGabrielle A Mandl, Malak Lahrichi, Perla Matar, et al.
Stem Cell Research & Therapy|July 14, 2025
ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumorsJean Pierre Bikorimana, Nehme El-Hachem, Gabrielle A Mandl, et al.
Iscience|March 10, 2025
Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapyJean Pierre Bikorimana, Roudy Farah, Jamilah Abusarah, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 5, 2025
Mesenchymal stromal cells 2.0: thinking outside the boxGabrielle A Mandl, Malak Lahrichi, Perla Matar, et al.
Stem Cell Research & Therapy|July 14, 2025
ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumorsJean Pierre Bikorimana, Nehme El-Hachem, Gabrielle A Mandl, et al.
Iscience|March 10, 2025
Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapyJean Pierre Bikorimana, Roudy Farah, Jamilah Abusarah, et al.
Pageof 1